Market Closed -
Swiss Exchange
16:30:41 31/05/2024 BST
|
5-day change
|
1st Jan Change
|
284.8
CHF
|
-0.18%
|
|
-3.20%
|
+3.79%
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Capitalization
1 |
11,231
|
15,781
|
24,153
|
16,147
|
15,568
|
16,978
|
-
|
-
|
Enterprise Value (EV)
1 |
11,894
|
15,864
|
25,161
|
17,643
|
16,928
|
18,285
|
18,175
|
17,971
|
P/E ratio
|
23
x
|
27.2
x
|
37.4
x
|
25.1
x
|
26
x
|
26.8
x
|
23.4
x
|
21
x
|
Yield
|
1.66%
|
1.28%
|
1.14%
|
1.71%
|
1.65%
|
1.64%
|
1.8%
|
2.01%
|
Capitalization / Revenue
|
3.85
x
|
6.07
x
|
7.18
x
|
4.32
x
|
4.29
x
|
4.29
x
|
4.01
x
|
3.74
x
|
EV / Revenue
|
4.08
x
|
6.1
x
|
7.48
x
|
4.72
x
|
4.67
x
|
4.62
x
|
4.29
x
|
3.96
x
|
EV / EBITDA
|
16.7
x
|
18.8
x
|
25.9
x
|
17.9
x
|
18.5
x
|
17.4
x
|
15.7
x
|
14.1
x
|
EV / FCF
|
21.1
x
|
23.5
x
|
30.2
x
|
28
x
|
27.1
x
|
30.9
x
|
22.6
x
|
20.1
x
|
FCF Yield
|
4.74%
|
4.26%
|
3.32%
|
3.57%
|
3.69%
|
3.24%
|
4.42%
|
4.97%
|
Price to Book
|
5.41
x
|
5.74
x
|
9.82
x
|
7.34
x
|
6.32
x
|
6.77
x
|
5.96
x
|
5.49
x
|
Nbr of stocks (in thousands)
|
64,398
|
63,024
|
62,313
|
60,116
|
59,626
|
59,613
|
-
|
-
|
Reference price
2 |
174.4
|
250.4
|
387.6
|
268.6
|
261.1
|
284.8
|
284.8
|
284.8
|
Announcement Date
|
19/05/20
|
18/05/21
|
17/05/22
|
16/05/23
|
13/05/24
|
-
|
-
|
-
|
Fiscal Period: März |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net sales
1 |
2,917
|
2,602
|
3,364
|
3,738
|
3,627
|
3,954
|
4,235
|
4,542
|
EBITDA
1 |
710.1
|
842.2
|
971.1
|
986.4
|
916.1
|
1,053
|
1,158
|
1,275
|
EBIT
1 |
510
|
619.5
|
760
|
746.7
|
669.9
|
820.2
|
909.9
|
1,008
|
Operating Margin
|
17.48%
|
23.81%
|
22.59%
|
19.97%
|
18.47%
|
20.74%
|
21.48%
|
22.2%
|
Earnings before Tax (EBT)
1 |
502.4
|
600.4
|
728.2
|
715.6
|
647.3
|
779.3
|
883.7
|
968.8
|
Net income
1 |
483.2
|
581
|
649
|
647.5
|
601
|
635
|
717.5
|
782.1
|
Net margin
|
16.56%
|
22.33%
|
19.29%
|
17.32%
|
16.57%
|
16.06%
|
16.94%
|
17.22%
|
EPS
2 |
7.570
|
9.190
|
10.35
|
10.72
|
10.05
|
10.64
|
12.18
|
13.58
|
Free Cash Flow
1 |
563.7
|
675.2
|
834.5
|
629.6
|
624.7
|
592
|
803.3
|
893.2
|
FCF margin
|
19.32%
|
25.95%
|
24.81%
|
16.84%
|
17.22%
|
14.97%
|
18.97%
|
19.67%
|
FCF Conversion (EBITDA)
|
79.38%
|
80.17%
|
85.93%
|
63.83%
|
68.19%
|
56.24%
|
69.36%
|
70.05%
|
FCF Conversion (Net income)
|
116.66%
|
116.21%
|
128.58%
|
97.24%
|
103.94%
|
93.23%
|
111.96%
|
114.2%
|
Dividend per Share
2 |
2.900
|
3.200
|
4.400
|
4.600
|
4.300
|
4.660
|
5.113
|
5.720
|
Announcement Date
|
19/05/20
|
18/05/21
|
17/05/22
|
16/05/23
|
13/05/24
|
-
|
-
|
-
|
Fiscal Period: March |
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
1,491
|
1,070
|
1,532
|
1,604
|
1,760
|
1,847
|
1,892
|
1,753
|
1,874
|
EBITDA
|
368.7
|
327.7
|
514.5
|
477
|
494.1
|
482.8
|
-
|
-
|
-
|
EBIT
1 |
268.8
|
230
|
389.5
|
372.2
|
387.8
|
363.8
|
382.9
|
350
|
319.9
|
Operating Margin
|
18.03%
|
21.5%
|
25.42%
|
23.21%
|
22.03%
|
19.7%
|
20.24%
|
19.97%
|
17.07%
|
Earnings before Tax (EBT)
1 |
266.4
|
219.8
|
-
|
353
|
-
|
350.5
|
365.1
|
293.7
|
353.6
|
Net income
1 |
127.8
|
204.1
|
376.9
|
294.8
|
354.2
|
291.9
|
355.6
|
249.6
|
351.4
|
Net margin
|
8.57%
|
19.08%
|
24.6%
|
18.38%
|
20.12%
|
15.81%
|
18.8%
|
14.24%
|
18.75%
|
EPS
2 |
2.050
|
3.230
|
5.960
|
4.660
|
5.690
|
-
|
5.940
|
4.110
|
5.940
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19/05/20
|
16/11/20
|
18/05/21
|
15/11/21
|
17/05/22
|
14/11/22
|
16/05/23
|
21/11/23
|
13/05/24
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net Debt
1 |
663
|
83.3
|
1,008
|
1,496
|
1,360
|
1,307
|
1,197
|
993
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.9337
x
|
0.0989
x
|
1.038
x
|
1.517
x
|
1.484
x
|
1.242
x
|
1.034
x
|
0.7786
x
|
Free Cash Flow
1 |
564
|
675
|
835
|
630
|
625
|
592
|
803
|
893
|
ROE (net income / shareholders' equity)
|
22.1%
|
24.4%
|
25.2%
|
29.1%
|
25.7%
|
26.5%
|
27.1%
|
27.4%
|
ROA (Net income/ Total Assets)
|
11%
|
11.2%
|
11.3%
|
12.1%
|
10.6%
|
11.9%
|
13%
|
13.3%
|
Assets
1 |
4,389
|
5,206
|
5,757
|
5,357
|
5,667
|
5,350
|
5,530
|
5,869
|
Book Value Per Share
2 |
32.20
|
43.60
|
39.50
|
36.60
|
41.30
|
42.00
|
47.80
|
51.90
|
Cash Flow per Share
2 |
13.20
|
12.10
|
15.00
|
13.00
|
12.60
|
13.40
|
16.10
|
17.10
|
Capex
1 |
129
|
89.2
|
107
|
154
|
129
|
150
|
156
|
168
|
Capex / Sales
|
4.42%
|
3.43%
|
3.17%
|
4.13%
|
3.55%
|
3.8%
|
3.69%
|
3.7%
|
Announcement Date
|
19/05/20
|
18/05/21
|
17/05/22
|
16/05/23
|
13/05/24
|
-
|
-
|
-
|
Last Close Price
284.8
CHF Average target price
279.1
CHF Spread / Average Target -2.00% Consensus |
1st Jan change
|
Capi.
|
---|
| +3.79% | 18.79B | | -13.72% | 20.65B | | +8.00% | 14.03B | | -20.38% | 1.99B | | +3.10% | 1.76B | | +8.31% | 1.33B | | +6.05% | 552M | | -.--% | 421M | | +69.47% | 196M | | +11.28% | 88.9M |
Medical Prosthetics
|